FDA warns of increased myopathy risk with high dose Zocor - MPR
Links shared publicly online about this topic.
- 1,303total visits
FDA warns of increased myopathy risk with high dose Zocor - MPR
empr.com —
View full resource at empr.com
Tags: Cholesterol Medication, Drug, Healthcare, FDA, Zocor, Merck & Co.
Most Recently Shared on March 19, 2010 at 7:49 pm By:
MPR News: FDA warns of increased myopathy risk with high dose Zocor: The FDA has notified healthcare professionals... http://bit.ly/djbxm8
FDA Announces New Limits On High-Dose Simvastatin (Zocor)
medicalnewstoday.com — “The United States Food and Drug Administration (FDA) today announced new limitations to the use of high-dose simvastatin, due to the increased risk of muscle pain and weakness (myopathy) and in ra” View full resource at medicalnewstoday.com
Most Recently Shared on June 9, 2011 at 12:05 pm By:
FDA Announces New Limits On High-Dose Simvastatin (Zocor) http://mnt.to/3WZf #heart #heartdisease
High-Dose Simvastatin Associated With Increased Risk for Myopathy, FDA Warns
profreg.medscape.com — “High-Dose Simvastatin Associated With Increased Risk for Myopathy, FDA Warns” View full resource at profreg.medscape.com
Most Recently Shared on March 23, 2010 at 9:06 am By:
James Rudd Internist, Cardiologist, Physician, and Doctor
High-Dose Simvastatin Associated With Increased Risk for Myopathy, FDA Warns http://www.medscape.com/viewarticle/718869
FDA issues warning for high doses of Zocor | Reuters
reuters.com — “WASHINGTON (Reuters) - Patients on the highest approved dose of the cholesterol-lowering drug Zocor may be at increased risk of muscle injury, U.S. regulators warned on Friday.Made by Merck & Co” View full resource at reuters.com
Most Recently Shared on March 20, 2010 at 1:52 am By:
B.J. Hardick, MD Health Communicator, Doctor, CAM, and Chiropractor
FDA issues warning for high doses of Zocor -- http://bit.ly/9JGyYi -- do the smaller doses just kill your muscles, kidneys, and you, slower?
FDA issues warning for high doses of Zocor | Reuters
reuters.com — “WASHINGTON (Reuters) - Patients on the highest approved dose of the cholesterol-lowering drug Zocor may be at increased risk of muscle injury, U.S. regulators warned on Friday. Made by Merck & Co” View full resource at reuters.com
Most Recently Shared on March 20, 2010 at 12:45 am By:
Najeh Ahmad, MD MPH Doctor, Family Medicine Doctor, and Physician
FDA issues warning for high doses of Zocor http://link.reuters.com/zej54j @Reuters
FDA issues warning for high doses of Zocor | Reuters
reuters.com — “WASHINGTON (Reuters) - Patients on the highest approved dose of the cholesterol-lowering drug Zocor may be at increased risk of muscle injury, U.S. regulators warned on Friday. Made by Merck & Co” View full resource at reuters.com
Most Recently Shared on March 19, 2010 at 8:03 pm By:
FDA issues warning for high doses of Zocor: WASHINGTON (Reuters) - Patients on the highest approved d... http://bit.ly/9AB1FP #health #news
FDA issues warning for high doses of Zocor | Reuters
feeds.reuters.com — “WASHINGTON (Reuters) - Patients on the highest approved dose of the cholesterol-lowering drug Zocor may be at increased risk of muscle injury, U.S. regulators warned on Friday. Made by Merck & Co” View full resource at feeds.reuters.com
Most Recently Shared on March 19, 2010 at 8:03 pm By:
HealthIT Policy Health News and Health IT
FDA issues warning for high doses of Zocor: WASHINGTON (Reuters) - Patients on the highest approved dose of the ch... http://bit.ly/9F3GOY
FDA issues warning for high doses of Zocor | Reuters
feeds.reuters.com — “WASHINGTON (Reuters) - Patients on the highest approved dose of the cholesterol-lowering drug Zocor may be at increased risk of muscle injury, U.S. regulators warned on Friday. Made by Merck & Co” View full resource at feeds.reuters.com
Most Recently Shared on March 19, 2010 at 7:51 pm By:
FDA issues warning for high doses of Zocor http://link.reuters.com/zej54j
FDA warns of increased myopathy risk with high dose Zocor - ONA
oncologynurseadvisor.com — “The FDA has notified healthcare professionals that there may be an increased risk of myopathy associated with the highest approved dose of Zocor (simvastatin, from Merck) 80mg, compared to lower simvastatin doses and possibly other drugs in the --statin-- class.” View full resource at oncologynurseadvisor.com
Most Recently Shared on March 19, 2010 at 6:56 pm By:
OncologyNurseAdvisor Nursing, Medical Education, Medical Publisher, and Oncology
FDA warns of increased myopathy risk with high dose Zocor http://goo.gl/fb/OK5n
Advertisement
